Stakeholders around the world can benefit from RWD as it can improve patient outcomes and speed at which products come to market.
Chitra Lele, PhD
Advertisement
Dr. Chitra Lele is Chief Scientific Officer, Sciformix Corporation.
Articles by Chitra Lele, PhD
The need for proactive pharmacovigilance is being increasingly acknowledged by all companies, regardless of their size and product mix, writes Dr. Chitra Lele.
Advertisement
Latest Updated Articles
The Power of Proactive PharmacovigilancePublished: April 21st 2015 | Updated:
The Growing Importance of Real World DataPublished: February 18th 2017 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Next-Gen CDMOs: Keeping Pace With Industry Change
2
Novo Nordisk Submits Higher-Dose Wegovy Injectable for FDA Approval with Priority Voucher
3
Pharmaceutical Executive Daily: Novartis Cuts 550 Jobs
4
Novartis Planning Layoffs for 550 Positions at Switzerland Facility
5
